COMMUNIQUÉS West-GlobeNewswire

Precipio Takes Final Step towards Regaining Nasdaq Compliance
26/04/2019
Company announces 1-for-15 reverse stock split NEW HAVEN, Conn., April 26, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced that it has implemented a 1-for-15 [...]
Novo Nordisk receives positive opinion from the European regulatory authorities for Esperoct® (turoctocog alfa pegol, N8-GP) for the treatment of haemophilia A
26/04/2019
Bagsværd, Denmark, 26 April 2019 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of [...]
Emisphere Development Update
26/04/2019
ROSELAND, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for oral semaglutide, a glucagon-like [...]
Key Patent Coverage for Asklepion Pharmaceuticals’ Investigational Candidate Extended to 2036
26/04/2019
BALTIMORE, April 26, 2019 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of novel therapeutics for rare pediatric diseases, today [...]
European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals’ Ondexxya™ (andexanet alfa), the First and Only Antidote for the Reversal of Factor Xa Inhibitors
26/04/2019
– Major Advance in the Treatment of European Factor Xa Inhibitor Patients Hospitalized with Life-Threatening Bleeding – – Initial Launch in Select Countries to Begin 2H 2019 – SOUTH SAN FRANCISCO, Calif., April 26, 2019 [...]
CB2 Insights to Host FY2018 Earnings Call on May 1, 2019
26/04/2019
TORONTO, April 26, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its fiscal year [...]
Aequus Announces Filing of Prospectus Supplement and an Update to Previously Announced Public Offering of Convertible Debenture Units
26/04/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 26, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (the “ Company ”) (TSX-V: [...]
Nexstim Plc: Managers' Transactions
26/04/2019
Company announcement, Helsinki, 26 April 2019 at 4pm (EET) Nexstim Plc: Managers' Transactions Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( "Nexstim" or "Company" ), the targeted neuromodulation company developing and marketing [...]
Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run
26/04/2019
The community is invited to walk to support the March of Dimes mission for healthy moms and babies CARY, N.C., April 26, 2019 (GLOBE NEWSWIRE) -- Chiesi is proud to return as the signature sponsor of the 2019 Triangle [...]
Wildflower Featured in CannabisNewsAudio Broadcast Examining Rare Opportunities for Profit in Cannabis Market
26/04/2019
NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Broadcast titled, “The Cannabis Bonanza Has Just [...]
Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018
26/04/2019
DENVER, CO, April 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, the “Company”), an international adaptive healthcare solutions company, today [...]
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
26/04/2019
European Commission Approval Anticipated Within 90 Days NEWPORT BEACH, Calif., April 26, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on [...]
Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface and Back of the Eye Diseases
26/04/2019
In an experimental back of the eye, autoimmune uveitis (EAU) model to be reported in a poster presentation at ARVO 2019, nomacopan (Coversin) and its long acting variants administered intravitreally, reported: ○ [...]
Oncology Venture Investor Events in Q2 2019 – new event
26/04/2019
Investor news Hørsholm, Denmark and Cambridge, MA, US, April 26th, 2019 – Oncology Venture A/S (“Oncology Venture”) today provided an update regarding when its CEO Peter Buhl Jensen are scheduled to make investor [...]
ReWalk Robotics Regains Compliance with Nasdaq Listing Rules 5550(a) and 5550(b)
26/04/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 26, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has regained compliance with Nasdaq Listing Rules [...]
Oncology Venture Investor Events in Q2 2019
26/04/2019
Investor news Oncology Venture Investor Events in Q2 2019 Hørsholm, Denmark and Cambridge, MA, US, April 26th, 2019 – Oncology Venture A/S (“Oncology Venture”) today provided an update regarding when its CEO Peter Buhl [...]
Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma
26/04/2019
-- Plan to evaluate Forty Seven’s CD47 antibody in combination with Genentech’s CD20 and PD-L1 antibodies with the aim of engaging both T-cell and macrophage components of the immune system against Diffuse Large B-cell [...]
Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development
26/04/2019
CRANBURY, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a clinical-stage biopharmaceutical company focused on developing its lead clinical program, ONS-5010, a [...]
Tauriga Sciences Inc. Creates Alternative Version of its Graphic Design for Mint Flavor Tauri-Gum Blister Pack
26/04/2019
New York, NY, April 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]

Pages